One Health Group in high demand as Labour backs NHS ‘Patient Choice’

One Health Group
[shareaholic app="share_buttons" id_name="post_below_content"]

One Health Group Plc (AQSE:OHGR) was featured in the Letters to Editor section of City A.M. this morning. 

Adam Binns, CEO of One Health Group commented “NHS and independent hospitals can be perceived as competitors, however a more nuanced view shows that referrals to the independent sector complement and enhance the services provided by the NHS. One of the critical roles that the independent sector serves is reducing operational strain on the NHS by treating significant numbers of NHS patients, freeing up the NHS to focus on more complex patient needs”. ‘Patient Choice’ is key to this. 

Wes Streeting, the UK Secretary of State for Health and Social Care, recently said “Labour would use the spare capacity in the private sector to get patients seen faster. Free at the point of use.”. GP’s can also empower patients with choice regarding who provides their treatment and where and when they receive it. If a patient is able to choose an independent sector provider, they may get quicker treatment and also help reduce the NHS waiting list, indirectly benefiting the public sector.

Binns continued, “despite the potential benefits, the integration of independent and NHS healthcare is not without challenges. Increasing inequality in access to healthcare services is a concern with more patients who can afford to ‘self-pay’ doing so out of frustration or desperation. This risks leading to a two-tier system where those who can afford to pay for private care have better access and possibly better outcomes.

As healthcare demands evolve, fostering a cooperative and collaborative environment between the NHS and independent sector, for the benefit of the patient, is crucial to ensure everyone receives timely, effective, and high-quality medical care, free at the point of delivery.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
One Health Group reports robust growth in H1 2024, with revenue up 22% and a 2% dividend increase, reflecting strong NHS demand and strategic expansion.
Discover how One Health Group plc plans to present its Half Year Results, marking its transition to IFRS as it eyes a potential AIM listing in 2025.
One Health Group plc (AQSE:OHGR) CEO Adam Binns discusses key drivers of revenue growth, NHS tariffs, and investment plans amid rising patient demand.
One Health Group CEO Adam Binns discusses H1 2024 revenue growth, NHS collaboration, and expansion plans, highlighting strategic healthcare innovations.
Explore how UK-listed companies like Diversified Energy and Dekel Agri-Vision are leading on sustainable innovation in energy production and agriculture.
Discover top-performing stocks across health, energy, finance, and telecom with insights from leading analysts to make informed investment decisions.

Search

Search